Policosanol (Reduchole22®) improves lipid profiles in HepG2 hepatocytes and Caco-2 enterocytes
Open Access
- 30 June 2025
- journal article
- Published by The Korean Society of Food Preservation in Food Science and Preservation
- Vol. 32 (3) , 498-508
Abstract
Lipid metabolism disorders such as hypercholesterolemia, hyperlipidemia, and hyperglycemia collectively characterize dyslipidemia, a condition marked by an imbalance in blood lipid levels and impaired lipid homeostasis. Policosanol, a mixture of long-chain alcohols derived from sugarcane, has been reported to improve lipid metabolism, but its cellular mechanisms remain underexplored. This study investigated the effects of policosanol (Reduchole22®) extracted using ethanol on lipid metabolism in HepG2 hepatocytes and Caco-2 enterocytes. The data were compared with atorvastatin, a widely used hyperlipidemia drug. Compared to the control group, 250-500 μg/mL of policosanol significantly reduced intracellular cholesterol and lipid accumulation via downregulating SREBP, ACAT, and APOB and upregulating LDL-receptor, ABCA1, and APOA1 in HepG2 cells. In addition, treatment of policosanol (250-500 μg/mL) markedly inhibited HMG-CoA reductase and ACAT2 expression, leading to decreased cholesterol and total lipid accumulation in Caco-2 cells. Moreover, policosanol suppressed H2O2-induced LDL oxidation in HepG2 cells, resulting in potential activity in preventing dyslipidemia. These findings suggest that policosanol (Reduchole22®) mediates cholesterol metabolism through mechanisms similar to atorvastatin. Moreover, it could be applied as a functional food ingredient for hyperlipidemia management in endogenous and exogenous cholesterol metabolism, providing a beneficial alternative in the food industry.Keywords
This publication has 36 references indexed in Scilit:
- Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysiseClinicalMedicine, 2024
- Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic DiseaseCellular and Molecular Gastroenterology and Hepatology, 2024
- Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024Obesity Pillars, 2024
- A 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Saccharum officinarum wax alcohols (Policosanol) on improvement of blood cholesterolJournal of King Saud University – Science, 2023
- Inhibition of HMG-CoA reductase activity and cholesterol permeation through Caco-2 cells by caffeoylquinic acids from Vernonia condensata leavesRevista Brasileira de Farmacognosia, 2016
- Barley sprout extract containing policosanols and polyphenols regulate AMPK, SREBP2 and ACAT2 activity and cholesterol and glucose metabolism in vitro and in vivoFood Research International, 2015
- Activation of AMP‐kinase by Policosanol Requires Peroxisomal MetabolismLipids, 2011
- Plant Sterol and Policosanol Characterization of Hexane Extracts from Grain Sorghum, Corn and their DDGSJournal of the American Oil Chemists' Society, 2009
- Differential effects of oxidized LDL on apolipoprotein AI and B synthesis in HepG2 cellsFree Radical Biology and Medicine, 2006
- Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cellsAtherosclerosis, 2005